Maurice Tillet was perhaps better known by his stage name, the “French Angel.” A Russian-born French professional wrestler, Tillet enjoyed a relatively successful career during his lifetime ...

Acromegaly is characterized by excessive growth hormone (GH) and insulin-like growth factor 1 (IGF-1) and affects quality of life and mortality. Oczyesa was submitted in a hybrid application ...

Crinetics is seeking to change the way acromegaly is treated. Ahead of its hopes for a 2025 U.S. drug launch, the biotech is looking to spread awareness about how to treat the condition.

A personalized treatment protocol was more effective for management of acromegaly -- also known as gigantism -- than the usual trial-and-error approach, the ...

Affected populations: Acromegaly is estimated to affect approximately 50 to 70 people out of every million. However, the true figure may be higher, as the symptoms develop slowly and thus may go ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved an oral form of the somatostatin analogue octreotide as a long-term maintenance therapy for ...

If you continue to have this issue please contact [email protected]. Adults with acromegaly and concomitant type 2 diabetes have increased risk for mortality, CV mortality and CV morbidity.

Acromegaly is a disease of the pituitary gland (a small gland found at the base of your brain) that causes too much growth hormone (somatotropin) to be produced. This can occur if there is a ...

If approved, paltusotine will be the first and only once-daily, oral, selective somatostatin receptor type 2 nonpeptide agonist available for adults living with acromegaly. “With our patient ...

Findings showed 56% of patients who received paltusotine achieved an IGF-1 level equal to or less than 1 times the ULN compared with 5% of those who received placebo. Treatment with paltusotine ...

SAN DIEGO — Crinetics Pharmaceuticals announced on Sunday that its experimental drug for acromegaly, a rare and serious hormonal disorder, succeeded in a late-stage trial, bringing the San Diego ...

Now, a study published in the Journal of Endocrinological Investigation offers a new hypothesis: the giants of Mont’e Prama could have been inspired by people with acromegaly, a medical condition that ...